Fate Therapeutics Inc (NASDAQ:FATE)

47.94
Delayed Data
As of Dec 03
 -4.66 / -8.86%
Today’s Change
47.01
Today|||52-Week Range
121.16
-47.28%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues2.4M4.4M4.1M4.7M
 
 
 
 
 
Depreciation And Amortization687.0K881.0K971.0K1.2M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses29.5M35.5M45.3M70.6M
 
 
 
 
 
Research And Development19.2M25.6M33.4M54.8M
 
 
 
 
 
Total Operating Expenses30.2M36.4M46.2M71.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-27.8M-32.0M-42.1M-67.1M
 
 
 
 
 
Extraordinary Charge0.000.00-118.0K0.00
 
 
Interest Expense On Debt2.2M1.6M1.3M1.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-30.0M-33.5M-43.0M-66.6M
 
 
 
 
 
Net Income-30.0M-33.5M-43.0M-66.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.5M31.8M42.0M56.2M
 
 
 
 
 
Shares To Calculate EPS Diluted25.5M31.8M42.0M56.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.18-$1.05-$1.02-$1.19
 
 
 
 
 
EPS Diluted-$1.18-$1.05-$1.02-$1.19